Kolis Scientific, Inc.: Series A $15.1M

January 30, 2007

developing an outpatient-based treatment for a common ophthalmic condition, has closed a $15.1M Series A financing led by Quaker BioVentures, De Novo Ventures and Spray Venture Partners.